Sponsor:
Charles Raison
Code:
NCT07719088
Conditions
Aging
Longevity
Biomarkers of Aging
Eligibility Criteria
Sex: All
Age: 60 - 70+
Healthy Volunteers: Accepted
Interventions
Psilocybin (Usona Institute)
Brief summary:
Conditions
Aging
Longevity
Biomarkers of Aging
Study ID
NCT07719088
Start date
Nov 16, 2026
Status verified date
Nov, 2026
Completion date
Dec, 2028
Anticipated
Primary completion date
Apr, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 60 - 70+
Healthy Volunteers: Accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
experimental: One 25mg Dose of Psilocybin
experimental: Two 25mg Doses of Psilocybin
experimental: Three 25mg Doses of Psilocybin
no intervention: Wait-list Comparator
Interventions
Psilocybin (Usona Institute)
Primary outcome measure
Central contacts
Locations
Vail Health Behavioral Health
Recruiting
Edwards, Colorado, United States, 81632
Contacts
Sponsor
Charles Raison
Last update posted
Nov 17, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-18. This information was provided to ClinicalTrials.gov by Charles Raison on 2026-11-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.